Starling Oncology (STLNW) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2026)
Analysis
Starling Oncology (STLNW) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | -4.52% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 15.16% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -1.49% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | -54.44% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | -19.19% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 64.13% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | 10.77% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | 17.42% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -0.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.59% |
| Mar 31, 2026 | 2.80% |
| Dec 31, 2025 | 7.72% |
| Sep 30, 2025 | 15.21% |
| Jun 30, 2025 | 21.75% |
| Mar 31, 2025 | 31.32% |
| Dec 31, 2024 | 41.55% |
| Dec 31, 2023 | 72.94% |